NDC00143-9502-01: HALOPERIDOL INJECTION.
The HALOPERIDOL INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAMUSCULAR, primary_container_type: VIAL, MULTIPLE DOSE, primary_container_content_quantity: 10.0 MILLILITERS, part_name_assigned_by_controlling_agency: HALOPERIDOL INJECTION, 10ML, VIAL. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-693-8815, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAMUSCULAR |
| primary_container_type | VIAL, MULTIPLE DOSE |
| primary_container_content_quantity | 10.0 MILLILITERS |
| part_name_assigned_by_controlling_agency | HALOPERIDOL INJECTION, 10ML, VIAL |
| NSN | 6505-01-693-8815 |
| ADMINISTRATION | INTRAMUSCULAR |
| PRIMARY CONTAINER CONTENT QUANTITY | 10.0 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |
| SPECIAL FEATURES | INDICATED FOR USE IN THE TREATMENT OF SCHIZOPHRENIA; HALOPERIDOL LACTATE5MG/ML, 10ML MULTIDOSE VIAL FOR INTRAMUSCULAR INJECTION; USED TO TREAT CERTAIN MENTAL/MOOD DISORDERS; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE); DO NOT FREEZE; PROTECT FROM LIGHT. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | HALOPERIDOL INJECTION, 10ML, VIAL |